Early kidney problem check for scleroderma and lupus patients
Part of Skin clinical trials.
This study checks how well your kidneys are working if you have scleroderma or lupus. It uses MRI and other tests to find kidney problems early, which could help protect your kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and have been diagnosed with systemic sclerosis (scleroderma) or systemic lupus erythematosus (lupus).
- You do not have any other autoimmune disease.
- You do not smoke.
- You do not have a current infection (like hepatitis B or C, HIV, or a chest infection) or a tumor (such as liver cancer).
- You do not have high blood pressure, diabetes, heart failure, liver disease, chronic kidney failure, or any urinary blockage.
- You have no metal implants or devices that prevent an MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.
This study aims to find better ways to detect kidney problems in people with lupus by testing blood and urine samples. If you have lupus, you may help researchers improve how kidney disease is diagnosed and monitored.
This study uses a simple blood test to estimate the risk of heart and blood vessel problems in people with lupus nephritis. It aims to find early signs of heart disease before symptoms appear.
This study looks at tiny particles in urine to better understand and monitor lupus-related kidney problems. It may help find better ways to track the disease without invasive biopsies.
This study is looking for biomarkers (clues in your blood, urine, or tissue) that can help predict how well lupus nephritis (kidney inflammation caused by lupus) responds to treatment. It focuses on people who have active kidney disease and are either starting treatment or have been on a stable treatment for at least a month.
This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.
Hear when a new Systemic Sclerosis and Systemic Lupus Erythematous trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.